1. Home
  2. KELYB vs DNA Comparison

KELYB vs DNA Comparison

Compare KELYB & DNA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Kelly Services Inc. Class B

KELYB

Kelly Services Inc. Class B

N/A

Current Price

$16.22

Market Cap

551.2M

ML Signal

N/A

Logo Ginkgo Bioworks Holdings Inc.

DNA

Ginkgo Bioworks Holdings Inc.

HOLD

Current Price

$8.46

Market Cap

455.8M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
KELYB
DNA
Founded
1946
2008
Country
United States
United States
Employees
4900
485
Industry
Professional Services
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
551.2M
455.8M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
KELYB
DNA
Price
$16.22
$8.46
Analyst Decision
Hold
Analyst Count
0
2
Target Price
N/A
$8.50
AVG Volume (30 Days)
4.1K
1.3M
Earning Date
05-07-2026
05-07-2026
Dividend Yield
1.95%
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$0.72
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$8.38
$5.37
52 Week High
$125.00
$17.58

Technical Indicators

Market Signals
Indicator
KELYB
DNA
Relative Strength Index (RSI) 54.62 50.12
Support Level $12.03 $7.69
Resistance Level $17.63 $9.78
Average True Range (ATR) 0.66 0.80
MACD -0.09 -0.02
Stochastic Oscillator 49.00 34.87

Price Performance

Historical Comparison
KELYB
DNA

About KELYB Kelly Services Inc. Class B

Kelly Services Inc is a specialty talent solutions company. The company operates through three reportable segments: i) Enterprise Talent Management, which provides temporary staffing, outsourcing, and permanent placement services across industrial, contact center, and clerical roles, ii) Science, Engineering & Technology, which supplies specialized talent across multiple industries, and iii) Education, which delivers staffing, placement, and executive search services to Pre-K-12 school districts and education organizations in the United States. The majority of the company's revenue is derived from the Enterprise Talent Management segment. Geographically, it generates the maximum revenue from the United States, followed by Europe and the Asia-Pacific Region.

About DNA Ginkgo Bioworks Holdings Inc.

Ginkgo Bioworks Holdings Inc is the platform for cell programming, providing flexible, end-to-end services that solve challenges for organizations across diverse markets, from food and agriculture to pharmaceuticals to industrial and specialty chemicals. The Company reorganized its operations into two operating and reportable segments: Cell Engineering engaged in providing biological R&D services for customers across a range of industries and Biosecurity that provides services to government and commercial customers to identify, monitor, prevent, mitigate, and ultimately protect humanity from biological threats. The maximum of revenue is from Cell Engineering Segment.

Share on Social Networks: